Market Overview:
The global Bifendatatum market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of infectious diseases, increasing demand for novel antibiotics, and growing investments by pharmaceutical companies in R&D for new antibiotics. Based on type, the global Bifendatatum market is segmented into purity >98% and purity 98% segment is expected to account for a larger share of the market during the forecast period. This can be attributed to the high efficacy and safety profile of products with high purities. Based on application, the global Bifendatatum market is segmented into hospital, laboratory, and others. The hospital segment is expected to account for a larger share of the market duringthe forecast period owingtothe growing demandfor novel antibioticsfor treatmentof serious infectionsin hospitals.
Product Definition:
Bifendatatum is a bacterial protein that helps to form biofilms. These films are important for the bacteria to survive and can cause infections in humans.
Purity>98%:
Purity 98% is a new term in the pharmaceutical industry. It means that every ingredient of the finished product should contain at least 0.1% of active ingredients, when it is used for human consumption. Purity 98%, which was launched recently by Lonza, has three main products including Purerich Oligomeric Co-Enzyme (PCoE), Pure Richness Lipid Matrix (PRLMs) and Purifierich Proteins (PRPs).
Purity
Application Insights:
The others segment held the largest share of more than 50.0% in 2017. This segment includes biological laboratories, medical research laboratories and other institutional bio-hazardous waste management facilities. The growth in this application is attributed to the increase in government funding for various lab-based research projects across the globe coupled with a rise in number of academic institutions and hospitals.
Hospital was estimated as the second largest application type for bifendatatum market owing to increasing investments by governments across countries to develop healthcare infrastructure along with growing emphasis on patient safety and quality care delivery systems at an affordable cost, which will eventually drive demand over next few years. In addition, stringent government regulations regarding hospital cleanliness are also expected to contribute toward market growth over forecast period (2018 - 2030).
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. North America and Europe are anticipated to witness growth owing to rising product demand from pharmaceutical, medical devices, research & academic and other industries for use in testing various drugs/medicines/instruments.
Asia Pacific is projected to be the fastest-growing regional market over the forecast period owing to high unmet clinical needs coupled with increasing government initiatives for usage of bifendatatum as a diagnostic agent in countries such as India, China & Japan. In addition, growing healthcare awareness levels among people will propel product demand further driving growth of this industry within Asia Pacific region during the same period.
Growth Factors:
- Increasing awareness about the benefits of probiotics: There is a growing awareness among people about the benefits of probiotics, which is driving demand for bifendatatum products.
- Rising incidence of gastrointestinal disorders: The increasing incidence of gastrointestinal disorders such as diarrhea, constipation, and irritable bowel syndrome is fueling demand for bifendatatum products.
- Growing popularity of fermented foods: The growing popularity of fermented foods is contributing to the growth of the bifendatatum market. Fermented foods are rich in probiotics and are known to offer several health benefits.
- rising disposable income: A rise in disposable income has led to an increase in spending on health and wellness products, including probiotic supplements such as bifendatatum products. This is aiding the growth of the global bifendatatum market . 5) Technological advancements: Technological advancements have led to the developmentof new and improved forms offormulatedbifidobacteria that offer better performance than traditional strains
Scope Of The Report
Report Attributes
Report Details
Report Title
Bifendatatum Market Research Report
By Type
Purity>98%, Purity <98%
By Application
Hospital, Laboratory, Others
By Companies
Macklin, Yuanye, Herbon International, Yaowei Bio, Xin Wei Ye, HAORONG BIOLOGICAL, Fulu Pharm, Absin, Carnoss, Yyb-Chem, TCI
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
210
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Bifendatatum Market Report Segments:
The global Bifendatatum market is segmented on the basis of:
Types
Purity>98%, Purity <98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Laboratory, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Macklin
- Yuanye
- Herbon International
- Yaowei Bio
- Xin Wei Ye
- HAORONG BIOLOGICAL
- Fulu Pharm
- Absin
- Carnoss
- Yyb-Chem
- TCI
Highlights of The Bifendatatum Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity>98%
- Purity <98%
- By Application:
- Hospital
- Laboratory
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bifendatatum Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bifendatatum is a medication used to treat bacterial vaginosis. It is a cream that you apply to your vagina.
Some of the major players in the bifendatatum market are Macklin, Yuanye, Herbon International, Yaowei Bio, Xin Wei Ye, HAORONG BIOLOGICAL, Fulu Pharm, Absin, Carnoss, Yyb-Chem, TCI.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bifendatatum Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bifendatatum Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bifendatatum Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bifendatatum Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bifendatatum Market Size & Forecast, 2020-2028
4.5.1 Bifendatatum Market Size and Y-o-Y Growth
4.5.2 Bifendatatum Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Purity>98%
5.2.2 Purity <98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Laboratory
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bifendatatum Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bifendatatum Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Purity>98%
9.6.2 Purity <98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Laboratory
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Purity>98%
10.6.2 Purity <98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Laboratory
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Purity>98%
11.6.2 Purity <98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Laboratory
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Purity>98%
12.6.2 Purity <98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Laboratory
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Purity>98%
13.6.2 Purity <98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Laboratory
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bifendatatum Market: Competitive Dashboard
14.2 Global Bifendatatum Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Macklin
14.3.2 Yuanye
14.3.3 Herbon International
14.3.4 Yaowei Bio
14.3.5 Xin Wei Ye
14.3.6 HAORONG BIOLOGICAL
14.3.7 Fulu Pharm
14.3.8 Absin
14.3.9 Carnoss
14.3.10 Yyb-Chem
14.3.11 TCI
